EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Angiotensin II type 1 receptor blockade inhibits gastric cancer metastasis through tight junction restoration

Sooraj Kakkat, Prabhat Suman, Sandeep Goswami, Brusi Kola, Kira A Bruno, Wendy L Frankel, Sujit Basu, Elba A Turbat-Herrera, Veronica Ramirez-Alcantara, Martin J Heslin, Joel F Andrews, Paramahansa Pramanik und 2 weitere

Cancer Letters · 2026-08 · 653 · 218530

DOI: 10.1016/j.canlet.2026.218530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-08. Verfasst von Sooraj Kakkat und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of South Alabama, Mobile, AL, 36617, USA; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 366…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Tight Junctions, Receptor, Angiotensin, Type 1, Angiotensin II Type 1 Receptor Blockers. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of South Alabama, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell-Cell adhesion maintained by tight junctions (TJs) is essential for epithelial integrity; loss of TJs correlates with poor prognosis, metastasis, and adverse clinical outcome in gastric cancer (GC). Restoring TJ integrity is therefore considered a promising therapeutic strategy in GC. The study identifies the stomach renin angiotensin system (stRAS) as a crucial regulator of TJ function in GC. Using integrative analysis of GC patient tissues, human GC cell lines, and orthotopic GC xenograft models, here we show that angiotensin II (ATII), the principal effector peptide of stRAS, drives TJ disassembly through an autocrine loop involving angiotensin receptor type 1 (AT1R) expressed on GC cells. Both ATII and AT1R are overexpressed in GC, where they suppress the expression of key TJ proteins. By analyzing global RNA-sequencing (RNA-seq) data and performing CRISPR/Cas9 gene deletion, chromatin immunoprecipitation, and functional assays, we mechanistically reveal that ATII, which is predominantly produced by cancer cells within the tumor microenvironment (TME), inhibits the expression of krüppel-like factor 4 (KLF4), a transcription factor crucial for the transcription of key TJ genes (CLDN1, 3, 4, and TJP1), leading to reduced synthesis of TJ proteins via AT1R expressed on cancer cells. Notably, the study demonstrates the effectiveness of pharmacological inhibition of AT1R with clinically established AT1R antagonists in preventing GC growth and metastasis by restoring TJ stability in vivo. These findings delineate a previously unrecognized role for ATII in governing TJ disassembly in GC and highlight the ATII/AT1R axis as a promising therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsTight JunctionsReceptor, Angiotensin, Type 1Angiotensin II Type 1 Receptor BlockersHumansAnimalsMiceCell Line, TumorXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticAngiotensin IIFemaleTumor Microenvironment

Stichwörter der Autor:innen

Angiotensin II receptor type 1Gastric cancerKruppel-like factor 4MetastasisTight junctions

Substanzen

Receptor, Angiotensin, Type 1Angiotensin II Type 1 Receptor BlockersAngiotensin II

Autor:innen und Institutionen

  • Department of Pathology, University of South Alabama, Mobile, AL, 36617, USA; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
  • Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
  • Department of Pathology, The Ohio State University, Columbus, OH, USA; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Department of Pathology, The Ohio State University, Columbus, OH, USA; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA; Department of Medical Oncology, The Ohio State University, Columbus, OH,…
  • Department of Mathematics and Statistics, University of South Alabama, Mobile, AL, 36688, USA.
  • Department of Pathology, University of South Alabama, Mobile, AL, 36617, USA; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA; Department of Biochemistry and Molecular Biology, University…

Förderung

  • University of South Alabama
  • U.S. Department of Defense

Zitieren

APA

Kakkat, S., Suman, P., Goswami, S., Kola, B., Bruno, K. A., Frankel, W. L., Basu, S., Turbat-Herrera, E. A., Ramirez-Alcantara, V., Heslin, M. J., Andrews, J. F., Pramanik, P., Sarkar, C., & Chakroborty, D. (2026). Angiotensin II type 1 receptor blockade inhibits gastric cancer metastasis through tight junction restoration. Cancer Letters, 653, 218530. https://doi.org/10.1016/j.canlet.2026.218530

Vancouver

Kakkat S, Suman P, Goswami S, Kola B, Bruno KA, Frankel WL, et al. Angiotensin II type 1 receptor blockade inhibits gastric cancer metastasis through tight junction restoration. Cancer Letters. 2026;653:218530. doi:10.1016/j.canlet.2026.218530

BibTeX
@article{Kakkat2026,
  author = {Kakkat, Sooraj and Suman, Prabhat and Goswami, Sandeep and Kola, Brusi and Bruno, Kira A and Frankel, Wendy L and Basu, Sujit and Turbat-Herrera, Elba A and Ramirez-Alcantara, Veronica and Heslin, Martin J and Andrews, Joel F and Pramanik, Paramahansa and Sarkar, Chandrani and Chakroborty, Debanjan},
  title = {Angiotensin II type 1 receptor blockade inhibits gastric cancer metastasis through tight junction restoration},
  journal = {Cancer Letters},
  year = {2026},
  volume = {653},
  pages = {218530},
  doi = {10.1016/j.canlet.2026.218530}
}
Kostenlos starten →